Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

January 24, 2021

Study Completion Date

February 1, 2021

Conditions

Healthy

Interventions

DRUG

LCB01-0371 tablet 400mg (Test drug, Batch# 3183817R)

Oral administration

DRUG

LCB01-0371 tablet 400mg (Reference drug, Batch# 1650006)

Oral administration

Trial Locations (1)

Seoul National University Bundang Hospital, Seongnam-si